These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 3099423)

  • 41. Pathways responsible for platelet hypersensitivity in rats with diabetes. I. Streptozocin-induced diabetes.
    Winocour PD; Kinlough-Rathbone RL; Mustard JF
    J Lab Clin Med; 1986 Feb; 107(2):148-53. PubMed ID: 3080538
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Platelet aggregation in human whole blood after chronic administration of aspirin.
    de la Cruz JP; Camara S; Bellido I; Carrasco T; Sanchez de la Cuesta F
    Thromb Res; 1987 Apr; 46(1):133-40. PubMed ID: 3109069
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Studies of aggregation using pairs of agonists in platelet concentrates stored for 5 days. Influence of autologous fresh plasma].
    Espinosa JI; César JM
    Sangre (Barc); 1990 Jun; 35(3):185-8. PubMed ID: 2118685
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Endothelin and platelet function.
    Ohlstein EH; Storer B; Nambi P; Given M; Lippton H
    Thromb Res; 1990 Mar; 57(6):967-74. PubMed ID: 2116686
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Disparate effects of the calcium-channel blockers, nifedipine and verapamil, on alpha 2-adrenergic receptors and thromboxane A2-induced aggregation of human platelets.
    Johnson GJ; Leis LA; Francis GS
    Circulation; 1986 Apr; 73(4):847-54. PubMed ID: 3004784
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Beta-adrenoceptor antagonists and human platelets: relationship of effects to lipid solubility.
    Kerry R; Scrutton MC; Wallis RB
    Biochem Pharmacol; 1984 Aug; 33(16):2615-22. PubMed ID: 6147145
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inhibition of platelet aggregation by moxalactam and free N-methylthiotetrazole.
    Ingalls CS; Somani P; Freimer EH
    Clin Ther; 1989; 11(5):640-51. PubMed ID: 2629724
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Role of arachidonic acid in platelet aggregation induced by S. typhimurium endotoxin].
    Tur'ianov MKh; Lomazova KD; Kazanskaia LV; Chumakova ZV; Poliakova AM
    Biull Eksp Biol Med; 1983 Sep; 96(9):33-5. PubMed ID: 6412781
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhibition of rabbit platelet aggregation by 1,4-naphthoquinones.
    Ko FN; Sheu SJ; Liu YM; Huang TF; Teng CM
    Thromb Res; 1990 Feb; 57(3):453-63. PubMed ID: 2156351
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Platelet aggregation in recombinant-hirudin-anticoagulated blood.
    Glusa E
    Haemostasis; 1991; 21 Suppl 1():116-20. PubMed ID: 1909991
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The roles of LAT in platelet signaling induced by collagen, TxA2, or ADP.
    Cho MJ; Pestina TI; Steward SA; Jackson CW; Kent Gartner T
    Biochem Biophys Res Commun; 2002 Apr; 292(4):916-21. PubMed ID: 11944902
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Action mechanism of the platelet aggregation inducer and inhibitor from Echis carinatus snake venom.
    Teng CM; Ma YH; Ouyang CH
    Biochim Biophys Acta; 1985 Jul; 841(1):8-14. PubMed ID: 3926005
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Investigation on a selective non-prostanoic thromboxane antagonist, BM 13.177, in human platelets.
    Patscheke H; Stegmeier K
    Thromb Res; 1984 Feb; 33(3):277-88. PubMed ID: 6424261
    [TBL] [Abstract][Full Text] [Related]  

  • 54. ADP and arachidonic acid induced platelet aggregation in schizophrenia and atypical psychoses.
    Whalley LJ; Reading HW; Rosie R
    Psychol Med; 1984 Feb; 14(1):207-11. PubMed ID: 6143339
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Relationship between structure and activity of aspirin-related compounds on the inhibition of in vitro platelet aggregation.
    Dupin JP; Gravier D; Casadebaig F; Boisseau MR; Bernard H
    Farmaco Sci; 1986 Mar; 41(3):205-14. PubMed ID: 3086120
    [TBL] [Abstract][Full Text] [Related]  

  • 56. XC 386: a new antiplatelet agent.
    Wang JP; Hsu MF; Tsai HY; Huang LJ; Teng CM
    Thromb Res; 1984 Oct; 36(2):113-22. PubMed ID: 6438827
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of benzydamine and other non-steroidal anti-inflammatory drugs on platelet aggregation induced by: arachidonic acid, ADP and collagen.
    Catanese B; Picollo R; Corradino C
    Boll Chim Farm; 1986 Jul; 125(7):228-33. PubMed ID: 3099811
    [No Abstract]   [Full Text] [Related]  

  • 58. Effects of N-acetylglucosamine and platelet inhibitors on the synergistic interaction of platelets and aggregating agents in the presence of wheat germ agglutinin.
    Tandon NN; Ordinas A; Jamieson GA
    Biochim Biophys Acta; 1982 Nov; 719(2):388-95. PubMed ID: 6817815
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of garlic extract and of three pure components isolated from it on human platelet aggregation, arachidonate metabolism, release reaction and platelet ultrastructure.
    Apitz-Castro R; Cabrera S; Cruz MR; Ledezma E; Jain MK
    Thromb Res; 1983 Oct; 32(2):155-69. PubMed ID: 6419374
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synergistic effects of platelet-activating factor and other platelet agonists in human platelet aggregation and release: the role of ADP and products of the cyclooxygenase pathway.
    Sturk A; Asyee GM; Schaap MC; van Maanen M; ten Cate JW
    Thromb Res; 1985 Nov; 40(3):359-72. PubMed ID: 2934863
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.